Meningitis: New Drug Recall, 29 Dead
Ameridose, which makes ready-to-use admixed preparations for hospital pharmacies, stopped production on Oct. 10, amid the growing scandal surrounding its sister company.
A sister company of the compounding pharmacy at the heart of the deadly fungal meningitis outbreak is voluntarily recalling all its products.
The agency said its labs have confirmed that 52 patients with fungal meningitis have Exserohilum rostratum in clinical specimens. Two other patients have a lab-confirmed fungal infection, one with Aspergillus fumigatus and one with Cladosporium.
Tennessee has reported the most deaths at 11, followed by Michigan with seven. Virginia, Florida, and Indiana have each reported three deaths, and Maryland and North Carolina have had one each.
All told, health officials have identified 368 cases of fungal meningitis, stroke as a result of presumed fungal meningitis, or other central nervous system-related infection, as well as nine cases of peripheral joint infection.